Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05576090 · ClinicalTrials.gov registry record · NA

UCLA REST Study (REsearch on Sleep Techniques)

A NA study of Inflammation and Sleep Disturbance, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT05576090: Recruiting NA study of Inflammation and Sleep Disturbance, sponsored by University of California, Los Angeles.

NCT05576090 is a NA study of Inflammation and Sleep Disturbance that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 240 participants, below the 286-participant average among 132 other Inflammation trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05576090, a NA study of Inflammation and Sleep Disturbance, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Sleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive feelings, loneliness, and fatigue over time. These symptoms, in turn, interfere with the ability to get a good night's rest. Sleep disruption can also upregulate inflammatory processes during the years of adolescence and young adulthood in ways that can create risk for the development of chronic health conditions (e.g., diabetes, depression, cardiovascular disease) in later adulthood. Sleep, however, is also a modifiable health behavior, leading many institutions to embark upon efforts to improve the sleep of their students. The challenge is to identify programs and interventions that can simultaneously improve sleep, be delivered at scale, and be easily completed by students. UCLA has developed and validated a group-based mindfulness intervention, Mindful Awareness Practices (MAPs), that has demonstrated beneficial effects on sleep in adults and may offer a promising, scalable approach for reducing sleep disturbance and improving associated psychological and biological outcomes in college students. However, this approach requires validation in this population relative to sleep education programs, which increasingly dominate the college landscape. To address this important public health problem, the investigators propose to conduct a single site, two-arm, parallel group randomized controlled trial to test the efficacy of the validated, group-based, six-week MAPs intervention vs. sleep education, an active time and attention matched control condition, for first and second year undergraduate students who report poor sleep at this critical transition year. The investigators are aiming to enroll approximately 240 participants. Participants will complete questionnaires, provide blood samples for

Primary Outcome

The PSQI includes 19 items, yielding seven dimensions of sleep: duration, disturbance, latency, daytime dysfunction, efficiency, quality, and sleeping medication use. Following standard procedure, we will obtain the PSQI global score by summing across all seven components. Each component has a maximum score of three points; the highest possible global score is 21. Higher PSQI global scores indicate poorer quality, with scores above 5 suggesting clinically-significant sleep disturbance. Our main

Interventions

  • BEHAVIORAL Sleep Education
  • BEHAVIORAL Mindfulness Meditation

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-04-03
Est. Completion 2027-06-30
Phase NA

What NCT05576090 shows while recruiting

NCT05576090 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 286-participant average among 132 other Inflammation trials with a reported enrollment target (16% lower).

The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Sleep Education is the first listed.

NCT05576090 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05576090 about?

NCT05576090 is a clinical study titled "UCLA REST Study (REsearch on Sleep Techniques)". Sleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive feelings, lonelines...

What is the current status of trial NCT05576090?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-04-03. Estimated completion is 2027-06-30.

What conditions does trial NCT05576090 study?

This clinical trial studies the following conditions: Inflammation, Sleep Disturbance, Psychosocial Functioning.

What interventions are being tested in trial NCT05576090?

The interventions under investigation include: Sleep Education (BEHAVIORAL), Mindfulness Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05576090?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05576090 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05576090's enrollment target sits among peer trials

240 24th of 132 higher than 108 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05576090, the US trial registry maintained by the National Library of Medicine. NCT05576090 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.